케토프로펜을 함유하는 고형 지질 나노파티클의 제조 및 평가 = Preparation and Evaluation of Ketoprofen-incorporated Solid Lipid Nanoparticles (SLN)

다국어 초록 (Multilingual Abstract)

Solid lipid nanoparticles (SLN) have been developed as a new drug delivery system. Although many particulate drug carriers, such as microsphere, liposome, niosome, emulsion, etc. have been introduced, they have some disadvantage: low efficiency of incorporation and stability, lack of reproducibility, and so on. Meanwhile. SLN as a new drug delivery system is known to entrap drugs with a high efficiency and a good reproducibility. Moreover, small size SLN can circulate in blood for a prolonged time. Although many preparation methods were introduced, microfluidization method is recommended to be the most useful. This study was attempted to prepare and evaluate ketoprofen-incorporated SLNs (keto-SLN), which were prepared by two methods. ultrasonication and microfluidization. Keto-SLN was evaluated by measurement of particle size and zeta potential, efficacy of entrapment, sedimentation volume, in virto release pattern. The mean particle size was about 0.1 ㎛, and the size was dependent on the type and the amount of emulsifier. Zeta potential was negative. -9∼13mV and entrapment efficacy was very high and stability was good for at least 60 days in the respect of particle size and sedimentation volume ratio. Analgesic effect was also determined as well as pharmacokinetic parameters. The former was comparable to that of that of ketoprofen loaded suspension (keto-sus) and the latter revealed that consistent with the delayed release of keto-SLN. T_(max) was longer than keto-sus. Therefore, keto-SLN was favourable dosage forms in the field of drug delivery system such as anti-cancer, analgesics and anti-inflammatory agents.